These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 29352069)

  • 1. Identification of Ketene-Reactive Intermediate of Erlotinib Possibly Responsible for Inactivation of P450 Enzymes.
    Zhao H; Li S; Yang Z; Peng Y; Chen X; Zheng J
    Drug Metab Dispos; 2018 Apr; 46(4):442-450. PubMed ID: 29352069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Icotinib Induces Mechanism-Based Inactivation of Recombinant Human CYP3A4/5 Possibly via Heme Destruction by Ketene Intermediate.
    Sun C; Zhao H; Li W; Jia Y; Yang Y; Peng Y; Zheng J
    Drug Metab Dispos; 2021 Oct; 49(10):892-901. PubMed ID: 34312304
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of Human Cytochrome P450 3A4 and 3A5 by Dronedarone and N-Desbutyl Dronedarone.
    Hong Y; Chia YM; Yeo RH; Venkatesan G; Koh SK; Chai CL; Zhou L; Kojodjojo P; Chan EC
    Mol Pharmacol; 2016 Jan; 89(1):1-13. PubMed ID: 26490246
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro bioactivation of dihydrobenzoxathiin selective estrogen receptor modulators by cytochrome P450 3A4 in human liver microsomes: formation of reactive iminium and quinone type metabolites.
    Zhang Z; Chen Q; Li Y; Doss GA; Dean BJ; Ngui JS; Silva Elipe M; Kim S; Wu JY; Dininno F; Hammond ML; Stearns RA; Evans DC; Baillie TA; Tang W
    Chem Res Toxicol; 2005 Apr; 18(4):675-85. PubMed ID: 15833027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytochrome P450-mediated bioactivation of the epidermal growth factor receptor inhibitor erlotinib to a reactive electrophile.
    Li X; Kamenecka TM; Cameron MD
    Drug Metab Dispos; 2010 Jul; 38(7):1238-45. PubMed ID: 20382753
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The grapefruit juice effect is not limited to cytochrome P450 (P450) 3A4: evidence for bergamottin-dependent inactivation, heme destruction, and covalent binding to protein in P450s 2B6 and 3A5.
    Lin HL; Kent UM; Hollenberg PF
    J Pharmacol Exp Ther; 2005 Apr; 313(1):154-64. PubMed ID: 15608076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic intermediate complex formation of human cytochrome P450 3A4 by lapatinib.
    Takakusa H; Wahlin MD; Zhao C; Hanson KL; New LS; Chan EC; Nelson SD
    Drug Metab Dispos; 2011 Jun; 39(6):1022-30. PubMed ID: 21363997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioactivation of the nontricyclic antidepressant nefazodone to a reactive quinone-imine species in human liver microsomes and recombinant cytochrome P450 3A4.
    Kalgutkar AS; Vaz AD; Lame ME; Henne KR; Soglia J; Zhao SX; Abramov YA; Lombardo F; Collin C; Hendsch ZS; Hop CE
    Drug Metab Dispos; 2005 Feb; 33(2):243-53. PubMed ID: 15523046
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-throughput cytochrome P450 loss and metabolic intermediate complex assays to aid in designing out of CYP3A inactivation.
    Russell DA; Cerny MA
    Methods Enzymol; 2023; 690():341-368. PubMed ID: 37858534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The inactivation of cytochrome P450 3A5 by 17alpha-ethynylestradiol is cytochrome b5-dependent: metabolic activation of the ethynyl moiety leads to the formation of glutathione conjugates, a heme adduct, and covalent binding to the apoprotein.
    Lin HL; Hollenberg PF
    J Pharmacol Exp Ther; 2007 Apr; 321(1):276-87. PubMed ID: 17251390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism-based inactivation of cytochrome P450 3A4 by 4-ipomeanol.
    Alvarez-Diez TM; Zheng J
    Chem Res Toxicol; 2004 Feb; 17(2):150-7. PubMed ID: 14967002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational explanation for bioactivation mechanism of targeted anticancer agents mediated by cytochrome P450s: A case of Erlotinib.
    Ai CZ; Liu Y; Li W; Chen DM; Zhu XX; Yan YW; Chen DC; Jiang YZ
    PLoS One; 2017; 12(6):e0179333. PubMed ID: 28628631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aryl acetylenes as mechanism-based inhibitors of cytochrome P450-dependent monooxygenase enzymes.
    Foroozesh M; Primrose G; Guo Z; Bell LC; Alworth WL; Guengerich FP
    Chem Res Toxicol; 1997 Jan; 10(1):91-102. PubMed ID: 9074808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanism-based inactivation of human liver cytochrome P450 2A6 by 8-methoxypsoralen.
    Koenigs LL; Peter RM; Thompson SJ; Rettie AE; Trager WF
    Drug Metab Dispos; 1997 Dec; 25(12):1407-15. PubMed ID: 9394031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prediction of Drug-Induced Liver Injury in HepG2 Cells Cultured with Human Liver Microsomes.
    Choi JM; Oh SJ; Lee JY; Jeon JS; Ryu CS; Kim YM; Lee K; Kim SK
    Chem Res Toxicol; 2015 May; 28(5):872-85. PubMed ID: 25860621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Chemoproteomic Platform To Assess Bioactivation Potential of Drugs.
    Sun R; Shi F; Liu K; Fu L; Tian C; Yang Y; Tallman KA; Porter NA; Yang J
    Chem Res Toxicol; 2017 Oct; 30(10):1797-1803. PubMed ID: 28960974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism-based inactivation of human cytochrome P450 1A2 and 3A4 isoenzymes by anti-tumor triazoloacridinone C-1305.
    Potęga A; Fedejko-Kap B; Mazerska Z
    Xenobiotica; 2016 Dec; 46(12):1056-1065. PubMed ID: 26928326
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidative bioactivation of nitrofurantoin in rat liver microsomes.
    Li H; Lin D; Peng Y; Zheng J
    Xenobiotica; 2017 Feb; 47(2):103-111. PubMed ID: 27092978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NADPH-dependent covalent binding of [3H]paroxetine to human liver microsomes and S-9 fractions: identification of an electrophilic quinone metabolite of paroxetine.
    Zhao SX; Dalvie DK; Kelly JM; Soglia JR; Frederick KS; Smith EB; Obach RS; Kalgutkar AS
    Chem Res Toxicol; 2007 Nov; 20(11):1649-57. PubMed ID: 17907785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.